Financials data is unavailable for this security.
Cash flow in SEKView more
In 2023, Vicore Pharma Holding AB increased its cash reserves by 29.91%, or 76.82m. Cash Flow from Financing totalled 470.86m or -- of revenues. In addition the company used 249.58m for operations while cash used for investing totalled 144.46m.
Cash flow per share | -1.72 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 3.79 |
---|---|
Tangible book value per share | 3.78 |
More ▼
Balance sheet in SEKView more
Current ratio | 11.98 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼